Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

FibroGen Total Liabilities 2013-2025 | FGEN

FibroGen total liabilities from 2013 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
FibroGen Annual Total Liabilities
(Millions of US $)
2024 $420
2023 $607
2022 $612
2021 $545
2020 $385
2019 $322
2018 $352
2017 $351
2016 $294
2015 $274
2014 $243
2013 $189
2012 $143
FibroGen Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $362
2024-12-31 $420
2024-09-30 $488
2024-06-30 $505
2024-03-31 $574
2023-12-31 $607
2023-09-30 $597
2023-06-30 $597
2023-03-31 $567
2022-12-31 $612
2022-09-30 $563
2022-06-30 $563
2022-03-31 $568
2021-12-31 $545
2021-09-30 $505
2021-06-30 $529
2021-03-31 $397
2020-12-31 $385
2020-09-30 $341
2020-06-30 $393
2020-03-31 $347
2019-12-31 $322
2019-09-30 $280
2019-06-30 $267
2019-03-31 $304
2018-12-31 $352
2018-09-30 $365
2018-06-30 $355
2018-03-31 $349
2017-12-31 $351
2017-09-30 $304
2017-06-30 $293
2017-03-31 $291
2016-12-31 $294
2016-09-30 $289
2016-06-30 $287
2016-03-31 $266
2015-12-31 $274
2015-09-30 $263
2015-06-30 $269
2015-03-31 $232
2014-12-31 $243
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $189
2012-12-31 $143
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.038B $0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.420B 26.32
Zoetis (ZTS) United States $67.834B 24.61
Takeda Pharmaceutical (TAK) Japan $47.092B 9.61
Daiichi Sankyo, - (DSNKY) Japan $46.241B 23.70
BeOne Medicines - (ONC) Switzerland $33.942B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.788B 0.00
Summit Therapeutics (SMMT) United States $19.648B 0.00
Merck (MKKGY) Germany $16.685B 10.85
Shionogi (SGIOY) Japan $15.142B 15.17
United Therapeutics (UTHR) United States $14.076B 12.18
Neurocrine Biosciences (NBIX) United States $13.024B 38.85
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.246B 0.00
Corcept Therapeutics (CORT) United States $7.587B 63.72
Grifols, S.A (GRFS) Spain $7.384B 0.00
Ionis Pharmaceuticals (IONS) United States $6.830B 0.00
Stevanato Group S.p.A (STVN) Italy $6.714B 39.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.111B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.949B 14.02
NewAmsterdam Pharma (NAMS) Netherlands $2.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.796B 0.00
Hypermarcas (HYPMY) Brazil $2.559B 19.24
Catalyst Pharmaceuticals (CPRX) United States $2.456B 8.23
Centessa Pharmaceuticals (CNTA) United Kingdom $2.365B 0.00
Ocular Therapeutix (OCUL) United States $2.201B 0.00
Dyne Therapeutics (DYN) United States $1.778B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.591B 23.71
Guardian Pharmacy Services (GRDN) United States $1.512B 0.00
Harrow (HROW) United States $1.480B 0.00
ARS Pharmaceuticals (SPRY) United States $1.430B 0.00
Ardelyx (ARDX) United States $1.407B 0.00
Evotec AG (EVO) Germany $1.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.311B 0.00
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Enliven Therapeutics (ELVN) United States $1.171B 0.00
Collegium Pharmaceutical (COLL) United States $1.171B 6.40
Cronos Group (CRON) Canada $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.872B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.750B 0.00
ProKidney (PROK) United States $0.708B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.680B 7.00
Theravance Biopharma (TBPH) United States $0.652B 53.92
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Siga Technologies (SIGA) United States $0.614B 7.59
Bioventus (BVS) United States $0.607B 14.68
Organogenesis (ORGO) United States $0.596B 0.00
Relay Therapeutics (RLAY) United States $0.584B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Elite Pharmaceuticals (ELTP) United States $0.567B 0.00
Oruka Therapeutics (ORKA) United States $0.562B 0.00
USANA Health Sciences (USNA) United States $0.558B 11.43
Xencor (XNCR) United States $0.546B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.522B 0.00
Savara (SVRA) United States $0.520B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Esperion Therapeutics (ESPR) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.353B 0.00
4D Molecular Therapeutics (FDMT) United States $0.332B 0.00
Altimmune (ALT) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.06
AleAnna (ANNA) United States $0.283B 0.00
OmniAb (OABI) United States $0.244B 0.00
Galectin Therapeutics (GALT) United States $0.238B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
Lyell Immunopharma (LYEL) United States $0.207B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Korro Bio (KRRO) United States $0.187B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.183B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
Liminatus Pharma (LIMN) United States $0.107B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Surrozen (SRZN) United States $0.093B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.063B 0.00
DURECT (DRRX) United States $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.18
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Ainos (AIMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.02
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00